Dr Cornelis Hop
Genentech, USA

Dr. Cornelis E.C.A. Hop is head of the Small Molecule Drug Metabolism & Pharmacokinetics Department at Genentech (South San Francisco) and leads a team of about 50 scientists involved in acquisition of aDME data in support of drug discovery and development.  Before that he was a senior director at Pfizer (Groton, CT) and a Senior Research Fellow at Merck (Rahway, NJ).  Dr. Hop has a strong background in ADME sciences and biotransformation, PK prediction and bionalysis in particular.  He has authored more than 100 publications in refereed journals and made more than 50 external oral presentations at conference and universities.  His main professional interests are focused on novel approaches to improve the efficiency of the drug discovery and development process and to reduce compound attrition with an emphasis on the use of in silicio tools and more sophisticated ways to predicted human pharmacikinetics and dose.